Hypothermic Oxygenated Machine Perfusion of Extended Criteria Kidney Allografts From Brain Death Donors
1 other identifier
interventional
45
1 country
1
Brief Summary
Kidney transplantation (KT) has emerged as the mainstay of treatment for end-stage kidney disease. In an effort to address the widening gap between demand and supply of donor organs, there has been an increase in the numbers of "marginal" or functionally impaired renal allografts that had to be accepted for KT over the decades. The use of extended criteria donor (ECD) allografts is associated with a higher incidence of primary graft non-function (PNF) and/or delayed graft function (DGF). Hypothermic oxygenated machine perfusion (HOPE) has been successfully tested in pre-clinical experiments and in a few clinical series of donation after cardiac death (DCD) in liver transplantation. The present trial is an investigator-initiated pilot study on the effects of HOPE on ECD-allografts in donation after brain death (DBD) KT. Fifteen kidney allografts will be submitted to 2 hours of HOPE before implantation and are going to be compared to a case matched group transplanted after conventional cold storage (CCS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 5, 2017
CompletedFirst Submitted
Initial submission to the registry
December 8, 2017
CompletedFirst Posted
Study publicly available on registry
December 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2020
CompletedApril 7, 2020
April 1, 2020
1.8 years
December 8, 2017
April 3, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
DGF
DGF (defined as the need for dialysis in the first 7-days post-transplantation)
7 days post-transplant
Secondary Outcomes (8)
CRR2, CRR5
5 days post-transplant
postoperative complications
Subjects will be followed 6 months postoperatively
Cumulative postoperative complications
Subjects will be followed 6 months postoperatively
Duration of intensive care stay
Subjects will be followed 6 months postoperatively
Duration of hospital stay
Subjects will be followed 6 months postoperatively
- +3 more secondary outcomes
Study Arms (2)
Conventional cold storage
ACTIVE COMPARATORConventional static cold storage (CCS) on temperature 0-4 °C from organ procurement (historical case matched group)
Hypothermic oxygenated perfusion (HOPE)
EXPERIMENTALHOPE for 1 hour via the renal artery in a recirculating and pressure controlled system, Belzer (UW) machine perfusion solution, perfusate temperature 0-4 °C, perfusate oxygenation pO2 of 60-80 kPa Other Name: Hypothermic machine perfusion (HMP)
Interventions
HOPE for 1 hour via the renal artery in a recirculating and pressure controlled system, Belzer (UW) machine perfusion solution, perfusate temperature 0-4 °C, perfusate oxygenation pO2 of 60-80 kPa Other Name: Hypothermic machine perfusion (HMP)
Eligibility Criteria
You may qualify if:
- Dialysis-requiring Patients, suffering from end stage kidney disease, listed for KT and receiving ECD organs at the Department of Surgery and Transplantation, University Hospital RWTH Aachen, Aachen, Germany. Informed consent is obtained from all subjects participating in the trial by a qualified member of the study team.
- ECD is defined as followed: deceased donors \> 60 years and older, and those aged between 50-59 years with at least two of the following conditions: cerebrovascular cause of death, serum Creatinine greater than 1.5 mg/dL (132.6 µmol/L), history of arterial hypertension
You may not qualify if:
- Recipients of living donor kidney transplants
- Previous kidney transplantation
- Participation in other kidney related trials
- The subject is unwilling or unable to follow the procedures outlined in the protocol
- The subject is mentally or legally incapacitated
- Non-German or non-English speakers
- Family members of the investigators or employees of the participating department
- The subject is mentally or legally incapacitated
- The subject suffers from uncontrolled bacterial or viral infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Surgery and Transplantation, University Hospital RWTH Aachen
Aachen, 52074, Germany
Related Publications (2)
Meister FA, Czigany Z, Rietzler K, Miller H, Reichelt S, Liu WJ, Boecker J, Moeller MJ, Tolba RH, Hamesch K, Strnad P, Boor P, Stoppe C, Neumann UP, Lurje G. Decrease of renal resistance during hypothermic oxygenated machine perfusion is associated with early allograft function in extended criteria donation kidney transplantation. Sci Rep. 2020 Oct 20;10(1):17726. doi: 10.1038/s41598-020-74839-7.
PMID: 33082420DERIVEDMeister FA, Czigany Z, Bednarsch J, Bocker J, Amygdalos I, Morales Santana DA, Rietzler K, Moeller M, Tolba R, Boor P, Rohlfs W, Neumann UP, Lurje G. Hypothermic Oxygenated Machine Perfusion of Extended Criteria Kidney Allografts from Brain Dead Donors: Protocol for a Prospective Pilot Study. JMIR Res Protoc. 2019 Oct 14;8(10):e14622. doi: 10.2196/14622.
PMID: 31613224DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Georg Lurje, M.D.
RWTH Aachen University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Transplant Surgeon
Study Record Dates
First Submitted
December 8, 2017
First Posted
December 20, 2017
Study Start
December 5, 2017
Primary Completion
September 30, 2019
Study Completion
March 30, 2020
Last Updated
April 7, 2020
Record last verified: 2020-04